SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-010858
Filing Date
2018-08-02
Accepted
2018-08-02 16:06:51
Documents
45
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 437366
2 ex10-1.htm EX-10.1 42819
3 ex31-1.htm EX-31.1 17614
4 ex32-1.htm EX-32.1 6872
  Complete submission text file 0001493152-18-010858.txt   2576712

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE lixt-20180630.xml EX-101.INS 374497
6 XBRL SCHEMA FILE lixt-20180630.xsd EX-101.SCH 39651
7 XBRL CALCULATION FILE lixt-20180630_cal.xml EX-101.CAL 27347
8 XBRL DEFINITION FILE lixt-20180630_def.xml EX-101.DEF 146289
9 XBRL LABEL FILE lixt-20180630_lab.xml EX-101.LAB 247393
10 XBRL PRESENTATION FILE lixt-20180630_pre.xml EX-101.PRE 185876
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 18988287
SIC: 2834 Pharmaceutical Preparations